GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Aurobindo Pharma AUROPHARMA.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

1,855.30

+3.07%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Aurobindo Pharma

Our reporting

Next results

14 Feb 2027

Due on 14 Feb 2027. Analysts expect earnings of 21.31 a share on revenue of ₹102.97bn.

Past results

Reported against what analysts expected

4 Nov 20264 Aug 202620 May 20269 Feb 20265 Nov 20253 Aug 2025
Earnings per share19.3017.8615.8615.6714.6114.20
Forecast19.3717.3316.3315.9415.2416.68
Revenue₹101.22bn₹92.17bn₹88.53bn₹86.46bn₹82.86bn₹78.68bn
Forecast₹98.24bn₹90.05bn₹87.37bn₹84.66bn₹81.42bn₹82.11bn

Key events

  1. 20 Jul 20152-for-1 share split
  2. 10 Feb 20115-for-1 share split
  3. 23 Oct 20032-for-1 share split
  4. 7 Mar 20002-for-1 share split
  5. 26 Oct 19982-for-1 share split
  6. 19 Jan 1995Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.